COVID-19 and Vitamin D: Length of Hospital Stay and Mortality
Vitamin D Level: Reflections of a Public Health Issue in the COVID-19 Pandemic. Does it Affect Mortality and Length of Hospital Stay?
調査の概要
状態
詳細な説明
This research was conducted to examine the effect of vitamin D on mortality and hospital stay in COVID-19 disease. For this, the approval of the Ministry of Health and then the ethics committee was obtained. For this reason, patients with positive PCR tests and hospitalized patients with vitamin D levels in their biochemistry were included in the study.
The data of the patients were obtained from the medical records. Information such as age, gender, comorbidities, length of hospital stay, vitamin D level were included in the study. According to the statistical analyzes obtained from these data, it has been shown that vitamin D level has no effect on mortality and hospital stay in COVID-19 disease.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Ankara、七面鳥、06800
- Republic of Turkey Ministry of Health Ankara City Hospitals Neurology-Orthopedics Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- COVID-19 PCR (Polymerase Chain Reaction) test positive
- Vitamin D level in biochemical parameters
- Adult patients hospitalized for COVID-19
Exclusion Criteria:
-Patients using drugs that may affect vitamin D absorption, such as corticosteroids, cholesterol-lowering agents, phenobarbital and phenytoin-containing agents
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Patients with COVID-19 + with vitamin D levels
Patients with COVID-19 + and vitamin D levels were included in the study retrospectively.
Vitamin D level was categorized into 3 groups as inadequacy, deficiency and normal from medical records.
No intervention was made.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Level of Vitamin D
時間枠：1 month later
|
Vitamin D levels of patients with a diagnosis of COVID-10.
These results were categorized at the level of deficiency/insufficiency/normal.
|
1 month later
|
|
Relationship between vitamin D level and mortality
時間枠：1 month later
|
Relationship between survival and death by categorized vitamin D level.
|
1 month later
|
|
Relationship between vitamin D level and hospital stay
時間枠：1 month later
|
Length of hospital stay by categorized vitamin D level.
|
1 month later
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Effects of additional diseases (Diabetes mellitus, hypertension, etc.) on hospital stay and mortality
時間枠：1 month later.
|
Evaluation of the impact of comorbidities on survival during COVID-19 disease.
|
1 month later.
|
協力者と研究者
捜査官
- スタディディレクター：Levent Öztürk, MD、Republic of Turkey Ministry of Health Ankara City Hospitals Neurology-Orthopedics Hospital
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- YuksekIU-SCOZBEK001
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
ビタミンD欠乏症の臨床試験
-
University of UlsterDairy Council for Northern Ireland; Agri-food & Biosciences Institute; Center for Nutrition and...完了
-
University of UlsterNorthern Ireland Executive; HSC Public Health Agency完了
-
University of Eastern Finland完了ビタミン D 受容体標的遺伝子の発現 | 血清25(OH)D濃度フィンランド
-
Bispebjerg HospitalThe Danish Medical Research Council完了